Unlock instant, AI-driven research and patent intelligence for your innovation.

O-galactoside derivative with nitrobenzene thiazolyl and preparation method and application thereof

A compound and general formula technology, applied in the field of type 2 sodium-dependent glucose transporter inhibitors, can solve problems such as side effects and difficulty in controlling blood sugar in patients

Inactive Publication Date: 2015-04-22
FOSHAN SAIWEISI MEDICINE SCI & TECH
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These drugs have good therapeutic effects, but there are serious side effects in long-term treatment, and due to the existence of drug resistance, in some cases, it is difficult to control the patient's blood sugar in combination with drugs in time

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • O-galactoside derivative with nitrobenzene thiazolyl and preparation method and application thereof
  • O-galactoside derivative with nitrobenzene thiazolyl and preparation method and application thereof
  • O-galactoside derivative with nitrobenzene thiazolyl and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030]

[0031] 2.34 g (10 mmol) of II-1 and 3.48 g (10 mmol) of compound III were refluxed overnight in 20 mL of dry THF under nitrogen protection. TLC showed the reaction was complete. The reaction compound was poured into 100 mL of ice water, stirred, extracted with 50 mL×3 dichloromethane, combined and extracted organic phases, washed with saturated brine, dried over anhydrous sodium sulfate, and evaporated to dryness on a rotary evaporator to obtain a column of residue Purified by chromatography to obtain product IV-1, a white solid, ESI-MS, m / z=305 ([M+H] + ).

[0032] 2.43g (8mmol) of compound IV-1 was dissolved in 20mL of 95% ethanol, and 0.5g of Raney nickel was added, followed by catalytic hydrogenation at room temperature of 0.2MPa. After 12 hours the reaction was complete. The reaction mixture was suction filtered to remove the catalyst, the filtrate was evaporated to dryness on a rotary evaporator, and the residue obtained was V-1, a white solid, ESI-MS, m / z...

Embodiment 2-3

[0037] With reference to the operating steps of Example 1, the compounds listed in the following table have been prepared:

[0038]

[0039]

Embodiment 4

[0040] The preparation of embodiment 4 reference compound D1

[0041] In order to fully illustrate the beneficial effects of the compounds of the present invention, the applicant has recorded the findings during the experiment

[0042] Compound D1 (undisclosed) of the following formula is used as a pharmacodynamic reference compound.

[0043]

[0044] The synthesis method is as follows:

[0045]

[0046] 1.89 g (10 mmol) of II-4 and 3.48 g (10 mmol) of compound III were refluxed overnight in 20 mL of dry THF under nitrogen protection. TLC showed the reaction was complete. The reaction compound was poured into 100 mL of ice water, stirred, extracted with 50 mL×3 dichloromethane, combined and extracted organic phases, washed with saturated brine, dried over anhydrous sodium sulfate, and evaporated to dryness on a rotary evaporator to obtain a column of residue Purified by chromatography to obtain product IV-4, a white solid, ESI-MS, m / z=260 ([M+H] + ).

[0047] 2.07g ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of drugs relevant to diabetes, in particular to an SGLT2 inhibitor of an O-galactoside structure with nitrobenzene thiazolyl, a preparation method of the SGLT2 inhibitor and the application of the SGLT2 inhibitor. The structural general formula of the SGLT2 inhibitor is shown in the specification.

Description

technical field [0001] The invention relates to the field of medicine related to diabetes. Specifically, the present invention relates to a type 2 sodium-dependent glucose transporter (SGLT2) inhibitor containing a nitrobenzothiazolyl-based O-galactoside structure that has a therapeutic effect on type 2 diabetes, a preparation method and a pharmaceutical application. use. Background technique [0002] Diabetes patients worldwide are gradually increasing, and the vast majority of them are type 2 diabetes patients. The antidiabetic drugs currently in clinical use mainly include sulfonylureas, metformin, thiazolidinediones, α-glucosidase inhibitors, dipeptidyl peptidase-IV inhibitors and insulin drugs. These drugs have good therapeutic effects, but long-term treatment has serious side effects, and due to the existence of drug resistance, in some cases it is difficult to control the blood sugar of patients in combination with drugs in time. [0003] Sodium-dependent glucose t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07H15/26C07H1/00A61K31/7056A61P3/10
CPCC07H15/26C07H1/00
Inventor 蔡子洋
Owner FOSHAN SAIWEISI MEDICINE SCI & TECH